Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency

Congenital fibrinogen deficiency

Pharmacokinetic Model of Fibrinogen Plasma Levels After Fibrinogen Administration FIB Grifols Congenital Deficiency for On-demand Treatment and Surgical Prophylaxis Patient Blood Management for Massive Obstetric Hemorrhage Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen Deficiency Human Fibrinogen – Pharmacokinetics Pharmacokinetics, Efficacy, and Safety of Human Plasma-Derived Fibrinogen (FIB Grifols) in Patients With Congenital Afibrinogenemia Early Administration of Fibrinogen in Polytraumatized Patients With Hypofibrinogenemia: a Randomized Feasibility Trial Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap Efficacy and Safety Study of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency Fibrinogen Concentrate (Human) − Efficacy and Safety Study Safety and Efficacy of Fibryga in Congenital Fibrinogen Deficiency Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency